Fig. 1

Study population including high risk individuals who are candidate for at least moderate to intensity statin therapy based on 2018/2019 updated ACC/AHA guideline: Tehran lipids and glucose study (1999–2016). Suggested subgroups for statin therapy are highlighted. CVD cardiovascular disease, LDL low density lipoprotein cholesterol